Cargando…
Optimising Multi-stakeholder Practices in Patient Engagement: A Gap Analysis to Enable Focused Evolution of Patient Engagement in the Development and Lifecycle Management of Medicines
BACKGROUND: The PARADIGM consortium aimed to make patient engagement in the development and lifecycle management of medicines easier and more effective for all, with the development of new tools that fulfil robustly defined gaps where engagement is suboptimal. AIMS: To generate an inventory of gaps...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492561/ https://www.ncbi.nlm.nih.gov/pubmed/34181236 http://dx.doi.org/10.1007/s43441-021-00313-9 |
_version_ | 1784578939757264896 |
---|---|
author | Faulkner, S. D. Pittens, C. A. C. M. Goedhart, N. S. Davies, E. H. Manning, E. Diaz-Ponce, A. Jose Vicente Edo, Maria Prieto-Remón, L. Husain, L. Huberman, K. Boudes, M. Subramaniam, M. |
author_facet | Faulkner, S. D. Pittens, C. A. C. M. Goedhart, N. S. Davies, E. H. Manning, E. Diaz-Ponce, A. Jose Vicente Edo, Maria Prieto-Remón, L. Husain, L. Huberman, K. Boudes, M. Subramaniam, M. |
author_sort | Faulkner, S. D. |
collection | PubMed |
description | BACKGROUND: The PARADIGM consortium aimed to make patient engagement in the development and lifecycle management of medicines easier and more effective for all, with the development of new tools that fulfil robustly defined gaps where engagement is suboptimal. AIMS: To generate an inventory of gaps in patient engagement practices and process from existing global examples. METHODS: A large set of criteria for effective patient engagement previously defined via a multi-stakeholder Delphi method, were mapped under fourteen overarching themes. A gap analysis was then performed by twenty-seven reviewers against the resulting forty-six mapped criteria, on a sample of seventy initiatives from global databases. RESULTS: An inventory of gaps was identified including contextual information as to why the gaps exist. Our work identified general patterns where patient engagement was suboptimal—defined as; fragmented reporting and dissemination of patient engagement activities, and the fundamental principles defined in frameworks or guidance being poorly adhered to in actual practice. Specific gaps were identified for sixteen criteria. Additionally, it was also common to observe primary aspects of a process were addressed for a given criteria (i.e. training for roles and responsibilities) but a secondary context element was lacking (i.e. making training material accessible/understandable/meaningful to all participants). CONCLUSION: The results show that the evolution towards meaningful and systematic patient engagement is occurring, yet more importantly they provide clear directional insights to help enhance collaborative practices and co-design solutions. This targeted impact to catalyse a needs-oriented health system that integrates patient engagement at its core is essential. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s43441-021-00313-9. |
format | Online Article Text |
id | pubmed-8492561 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-84925612021-10-15 Optimising Multi-stakeholder Practices in Patient Engagement: A Gap Analysis to Enable Focused Evolution of Patient Engagement in the Development and Lifecycle Management of Medicines Faulkner, S. D. Pittens, C. A. C. M. Goedhart, N. S. Davies, E. H. Manning, E. Diaz-Ponce, A. Jose Vicente Edo, Maria Prieto-Remón, L. Husain, L. Huberman, K. Boudes, M. Subramaniam, M. Ther Innov Regul Sci Original Research BACKGROUND: The PARADIGM consortium aimed to make patient engagement in the development and lifecycle management of medicines easier and more effective for all, with the development of new tools that fulfil robustly defined gaps where engagement is suboptimal. AIMS: To generate an inventory of gaps in patient engagement practices and process from existing global examples. METHODS: A large set of criteria for effective patient engagement previously defined via a multi-stakeholder Delphi method, were mapped under fourteen overarching themes. A gap analysis was then performed by twenty-seven reviewers against the resulting forty-six mapped criteria, on a sample of seventy initiatives from global databases. RESULTS: An inventory of gaps was identified including contextual information as to why the gaps exist. Our work identified general patterns where patient engagement was suboptimal—defined as; fragmented reporting and dissemination of patient engagement activities, and the fundamental principles defined in frameworks or guidance being poorly adhered to in actual practice. Specific gaps were identified for sixteen criteria. Additionally, it was also common to observe primary aspects of a process were addressed for a given criteria (i.e. training for roles and responsibilities) but a secondary context element was lacking (i.e. making training material accessible/understandable/meaningful to all participants). CONCLUSION: The results show that the evolution towards meaningful and systematic patient engagement is occurring, yet more importantly they provide clear directional insights to help enhance collaborative practices and co-design solutions. This targeted impact to catalyse a needs-oriented health system that integrates patient engagement at its core is essential. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s43441-021-00313-9. Springer International Publishing 2021-06-28 2021 /pmc/articles/PMC8492561/ /pubmed/34181236 http://dx.doi.org/10.1007/s43441-021-00313-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Research Faulkner, S. D. Pittens, C. A. C. M. Goedhart, N. S. Davies, E. H. Manning, E. Diaz-Ponce, A. Jose Vicente Edo, Maria Prieto-Remón, L. Husain, L. Huberman, K. Boudes, M. Subramaniam, M. Optimising Multi-stakeholder Practices in Patient Engagement: A Gap Analysis to Enable Focused Evolution of Patient Engagement in the Development and Lifecycle Management of Medicines |
title | Optimising Multi-stakeholder Practices in Patient Engagement: A Gap Analysis to Enable Focused Evolution of Patient Engagement in the Development and Lifecycle Management of Medicines |
title_full | Optimising Multi-stakeholder Practices in Patient Engagement: A Gap Analysis to Enable Focused Evolution of Patient Engagement in the Development and Lifecycle Management of Medicines |
title_fullStr | Optimising Multi-stakeholder Practices in Patient Engagement: A Gap Analysis to Enable Focused Evolution of Patient Engagement in the Development and Lifecycle Management of Medicines |
title_full_unstemmed | Optimising Multi-stakeholder Practices in Patient Engagement: A Gap Analysis to Enable Focused Evolution of Patient Engagement in the Development and Lifecycle Management of Medicines |
title_short | Optimising Multi-stakeholder Practices in Patient Engagement: A Gap Analysis to Enable Focused Evolution of Patient Engagement in the Development and Lifecycle Management of Medicines |
title_sort | optimising multi-stakeholder practices in patient engagement: a gap analysis to enable focused evolution of patient engagement in the development and lifecycle management of medicines |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492561/ https://www.ncbi.nlm.nih.gov/pubmed/34181236 http://dx.doi.org/10.1007/s43441-021-00313-9 |
work_keys_str_mv | AT faulknersd optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines AT pittenscacm optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines AT goedhartns optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines AT davieseh optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines AT manninge optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines AT diazponcea optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines AT josevicenteedomaria optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines AT prietoremonl optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines AT husainl optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines AT hubermank optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines AT boudesm optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines AT subramaniamm optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines |